Corcept Wants Sun's Cushing's Syndrome Drug Blocked
Corcept Therapeutics Inc. has asked a New Jersey federal judge to block Sun Pharma's planned generic version of its flagship Cushing's syndrome medication Korlym, claiming three valid patents will be infringed....To view the full article, register now.
Already a subscriber? Click here to view full article